A Multi-center RCT Trial on Prognosis of Patients With Anticoagulation and DAPT Therapy After LAAC

Conditions:   Left Atrial Appendage Thrombosis;   Thrombi;   Stroke Interventions:   Drug: Rivaroxaban;   Drug: DAPT Sponsor:   Shanghai Zhongshan Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials